CTS implement the Bio-Rad Geenius HIV 1/2 supplemental assay on Monday September 21, 2020. The newly licensed Geenius test is an immunochromatographic assay designed to confirm and differentiate individual antibodies to Human Immunodeficiency Virus Types 1 and 2. The assay will be replacing the HIV-1 Western blot and HIV-2 EIA assays which are performed on samples with a reactive result on a licensed HIV 1/2 screening test.
Read all about it on the Communication page by clicking this link: Communications
On August 9, 2019, the new CTS Laboratory Information System was successfully implemented in St...
The CTS 2020 Annual Laboratory Survey is on its way to your email box. We would appreciate you takin...
That’s just one of the reasons that National Blood Donor Month, which has taken place each Jan...
The CTS Medical Advisory Board recently agreed upon a revision to our standard testing algorithm thi...
Daylight Saving Time Begins March 10, 2019. As a friendly reminder, airlines often change their rout...
As a friendly reminder, airlines often change their routine flights and cargo hours for holidays. We...